Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 1Brain Neoplasms 1

Interventions

Specimen Handling 640pembrolizumab 570Magnetic Resonance Spectroscopy 550Carboplatin 430Cyclophosphamide 382Cisplatin 376Biopsy 364Paclitaxel 312Nivolumab 310Gemcitabine 302Radiotherapy 275Bevacizumab 243Dexamethasone 213fludarabine 209Docetaxel 193durvalumab 182atezolizumab 179Oxaliplatin 173Rituximab 168Fluorouracil 168venetoclax 167Pemetrexed 165Doxorubicin 163Radiation 161Capecitabine 161Radiosurgery 149Etoposide 138Ipilimumab 136Leucovorin 134Lenalidomide 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fluorine-18 × 90 days × Clear all
NCT05937776 2026-06-05

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

OHSU Knight Cancer Institute

Completed
4 enrolled
CNS

Glioma

NCT06474533 2026-04-03

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

University of California, San Francisco

Recruiting
199 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡